ICON supports the development and analysis of a broad range of biomarker assays across many therapeutic areas
Our global laboratory groups (Bioanalytical, Central and Imaging) and our Clinical Pharmacodynamics team have the expertise, scale and range of instrumentation to provide the right biomarker solution and the highest quality data to support critical decision making in drug development.
ICON offers industry leading expertise in biomarker services, praised by our clients for our customised approach to delivering personalised, timely solutions.